Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | I-BET151 | 0.316 | 1.000 | uM | 72 | hr | 1 | 1276 | 733 | 0.1255 | 0.1085 | 0.5745 | 0.5981 |
COLO 858 | Vemurafenib | I-BET151 | 0.316 | 1.000 | uM | 72 | hr | 2 | 1178 | 702 | 0.1100 | 0.1085 | 0.5959 | 0.5981 |
COLO 858 | Vemurafenib | I-BET151 | 0.316 | 1.000 | uM | 72 | hr | 3 | 1034 | 645 | 0.0899 | 0.1085 | 0.6238 | 0.5981 |
COLO 858 | Vemurafenib | I-BET151 | 1.000 | 0.000 | uM | 72 | hr | 1 | 1055 | 482 | 0.1324 | 0.1445 | 0.4569 | 0.4584 |
COLO 858 | Vemurafenib | I-BET151 | 1.000 | 0.000 | uM | 72 | hr | 2 | 1148 | 502 | 0.1493 | 0.1445 | 0.4373 | 0.4584 |
COLO 858 | Vemurafenib | I-BET151 | 1.000 | 0.000 | uM | 72 | hr | 3 | 1266 | 609 | 0.1518 | 0.1445 | 0.4810 | 0.4584 |
COLO 858 | Vemurafenib | I-BET151 | 1.000 | 1.000 | uM | 72 | hr | 1 | 1426 | 1073 | 0.0816 | 0.0720 | 0.7525 | 0.7523 |
COLO 858 | Vemurafenib | I-BET151 | 1.000 | 1.000 | uM | 72 | hr | 2 | 1278 | 957 | 0.0742 | 0.0720 | 0.7488 | 0.7523 |
COLO 858 | Vemurafenib | I-BET151 | 1.000 | 1.000 | uM | 72 | hr | 3 | 1068 | 807 | 0.0603 | 0.0720 | 0.7556 | 0.7523 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 0.000 | uM | 72 | hr | 1 | 1039 | 854 | 0.0428 | 0.0449 | 0.8219 | 0.8382 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 0.000 | uM | 72 | hr | 2 | 1213 | 1019 | 0.0448 | 0.0449 | 0.8401 | 0.8382 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 0.000 | uM | 72 | hr | 3 | 1385 | 1181 | 0.0471 | 0.0449 | 0.8527 | 0.8382 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 1 | 1460 | 1042 | 0.0966 | 0.0871 | 0.7137 | 0.7176 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 2 | 1381 | 996 | 0.0890 | 0.0871 | 0.7212 | 0.7176 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 3 | 1163 | 835 | 0.0758 | 0.0871 | 0.7180 | 0.7176 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.000 | 0.000 | uM | 72 | hr | 1 | 3640 | 233 | 1.0453 | 1.0000 | 0.0640 | 0.0538 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.000 | 0.000 | uM | 72 | hr | 2 | 3366 | 157 | 0.9846 | 1.0000 | 0.0466 | 0.0538 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.000 | 0.000 | uM | 72 | hr | 3 | 3331 | 169 | 0.9701 | 1.0000 | 0.0507 | 0.0538 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.000 | 1.000 | uM | 72 | hr | 1 | 2536 | 154 | 0.7308 | 0.6798 | 0.0607 | 0.0674 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.000 | 1.000 | uM | 72 | hr | 2 | 2283 | 159 | 0.6517 | 0.6798 | 0.0696 | 0.0674 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.000 | 1.000 | uM | 72 | hr | 3 | 2307 | 166 | 0.6569 | 0.6798 | 0.0720 | 0.0674 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.100 | 0.000 | uM | 72 | hr | 1 | 3365 | 184 | 0.9760 | 0.9612 | 0.0547 | 0.0512 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.100 | 0.000 | uM | 72 | hr | 2 | 3302 | 145 | 0.9686 | 0.9612 | 0.0439 | 0.0512 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.100 | 0.000 | uM | 72 | hr | 3 | 3239 | 178 | 0.9391 | 0.9612 | 0.0550 | 0.0512 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.100 | 1.000 | uM | 72 | hr | 1 | 1859 | 768 | 0.3347 | 0.3130 | 0.4131 | 0.4335 |